Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

NCT01336738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes, Type 2

Interventions

DRUG: Placebo
DRUG: 150 mg PF-04991532
DRUG: 450 mg PF-04991532
DRUG: 750 mg PF-04991532
DRUG: Sitagliptin 100 mg

Sponsor

Pfizer